Defy Medical review

Defy Medical is a Tampa-based practice offering telemedicine and in-person services across hormone care, weight management and other treatment areas. Its public about page identifies medical director Justin Saya and links professional profiles. These disclosures provide a starting point for understanding the practice, rather than verification of the assigned professional’s license or a guarantee that every treatment is appropriate. The practice promotes extended consultations and individualized plans supported by laboratory assessment. Ask which clinician will provide the encounter, what records are required and whether a further in-person assessment is needed before deciding what medication or monitoring may be suitable.

Costs are individualized rather than a single monthly medication subscription. The TRT and women’s hormone FAQs provide illustrative first-year and later-year care averages, expressly warning that the actual total depends on deficiencies, symptoms, formulation, dose and additional medications. Those estimates include more than medication and should not be treated as binding quotes for a patient. The site also links a laboratory storefront, so a claim that no laboratory prices exist anywhere is too broad. Obtain an itemized price for the required consultation, selected tests, medication and follow-up, including which expenses arise before a prescription decision. The practice advertises no subscription or contract and payment for services used.

The intake workflow requires new-patient paperwork and relevant laboratory work before an initial consultation can be booked through the app or patient portal. Recent outside results may be accepted after review, depending on their age, included tests and whether the panel meets the practice’s requirements. Acceptance is not automatic, and additional testing can be requested. The clinical-procedures page describes hormone monitoring at least twice yearly and additional testing according to the response to treatment. Confirm the actual schedule and cost for the selected program rather than applying one fixed follow-up calendar to every hormone or weight-care patient.

The peptide page lists BPC-157, TB-500, epithalon, KPV, MOTS-c and sermorelin alongside broad recovery, cognition, sleep and healthy-aging claims. The existence of a service page does not establish current stock, a prescription for every reader or compliance with the conditions governing a particular compounded ingredient. FDA-approved products, qualifying compounded preparations and authorized research access are different pathways. The reviewed page does not establish the appropriate routine pathway for each investigational listing. Human evidence also varies substantially by exact molecule, route and outcome. A biological mechanism or an experienced provider should not turn limited research into a proven personal benefit.

The GLP-1 FAQ describes injections as well as oral disintegrating tablets and liquid drops. These formulations should not be assumed equivalent to FDA-approved products or to reproduce the results from branded-drug trials. Ask whether the proposed prescription is an approved brand or a compounded preparation, what ingredient and route it uses and what evidence supports that formulation. The practice describes a network of outside pharmacies meeting quality standards, without establishing the specific dispensing site for the selected order. Identify that facility and verify its authorization and instructions. The current state FAQ excludes Mississippi; individual clinical, laboratory and pharmacy restrictions still need confirmation.

Refund rules contain a material inconsistency. Current terms describe laboratory orders valid for twelve months with a possible twelve-month renewal and an account credit for eligible unused orders, minus a processing fee. The clinical-procedures page instead describes three-month validity, a three-month renewal and different original-payment versus store-credit windows. Both require any cancellation before the laboratory sample is submitted, but a patient should obtain the applicable rule in writing before purchasing. Consultation cancellation within twenty-four hours or a missed visit can carry the full fee, and an unfavorable prescription outcome alone does not create a refund. Ordinary insurance is not accepted; a supplied receipt or superbill does not guarantee reimbursement.